Perlen Packaging und Cipatex schließen Zusammenarbeit
The CPH Group announced back in August 2020 that its Packaging Division would be investing in a new PVdC coating facility at its Anápolis site in Brazil which should commence operations in the fourth quarter of 2022. To ensure that the new facility can also be supplied with domestically produced mono PVC films, the Packaging Division has now concluded an exclusive collaboration with Brazil-based mono PVC film manufacturer Cipatex. As part of the new collaboration, CPH will support the modernization of a calendering facility at Cipatex’s São Paulo plant to align it fully to pharmaceutical mono PVC film requirements. The films produced will then be further processed at Perlen Packaging’s Anápolis plant and coated with PVdC.
“The new Anápolis film coating facility will be our Packaging Division’s third, joining similar plants in Switzerland and China, in line with our overall strategy of maintaining our own coating capacities in the pharmaceuticals sector’s key centres in Europe, Asia and the Americas,” says Peter Schildknecht, CEO of the CPH Group. “And our collaboration with Cipatex will ensure that our new Anápolis plant is assured of local supplies of high-quality mono PVC films.” This underlines the division's strategy of ensuring the long-term and reliable supply of raw materials to the production sites.
“The demand for pharmaceutical packaging solutions has been growing steadily in the Latin American market – and in Brazil in particular – since we commenced our activities in South America over 20 years ago,” adds Marc Haller, Head of the Packaging Division of the CPH Group. “With our investment in our Anápolis site and our new partnership with Cipatex, we can offer the full range of products – from mono films to coated blister pack films – from our local Brazilian production facilities.”
Perlen Packaging’s Anápolis site is located in Brazil’s rapidly growing second-biggest pharmaceutical industry cluster. Many of the country’s leading pharmaceutical customers are sited nearby.
The latest market projections confirm the continuing growth trend in Latin America’s pharmaceuticals markets, which are expected to show annual growth of between 5 and 8 per cent between now and 2026. Brazil alone, with its more than 200 million inhabitants, is the world’s sixth-biggest pharmaceuticals market.
